NCT00152035View on ClinicalTrials.gov

Safety of SPD465 in Treating Adults With ADHD.

PHASE3CompletedINTERVENTIONAL
Enrollment

505

Participants

Timeline

Start Date

March 10, 2005

Primary Completion Date

November 7, 2006

Study Completion Date

November 7, 2006

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate.

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT00152035 - Safety of SPD465 in Treating Adults With ADHD. | Biotech Hunter | Biotech Hunter